Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients

National Hospital Organization Nagoya Medical Center, Nagoya

Nagoya Daini Red Cross Hospital, Nagoya

National Cancer Center Hospital East, Kashiwa

National Hospital Organization Shikoku Cancer Center, Matsuyama

Gunma University Hospital, Maebashi

National Hospital Organization Hokkaido Cancer Center, Sapporo

Hyogo Cancer Center, Akashi

Tokai University Hospital, Isehara

Tohoku University Hospital, Sendai

Osaka University Hospital, Suita

Shimane University Hospital, Izumo

Tochigi Cancer Center, Utsunomiya

National Cancer Center Hospital, Chūō

The Cancer Institute Hospital Japanese Foundation for Cancer Research, Koto

University of Fukui Hospital, Fukui

National Hospital Organization Kyushu Cancer Center, Fukuoka

Fukuoka University Hospital, Fukuoka

Imamura Bun-in Hospital, Kagoshima

National Hospital Organization Kumamoto Medical Center, Kumamoto

University Hospital, Kyoto Prefectural University of Medicine, Kyoto

Okayama University Hospital, Okayama